June 10, 2025 a 03:44 pm

BAX: Fundamental Ratio Analysis - Baxter International Inc.

Image of Baxter International Inc.

Baxter International Inc., a leader in healthcare products, demonstrates a stable yet cautious outlook for investors. Despite facing challenges in ROE and other financial metrics, the company continues to expand through its diverse healthcare offerings worldwide. Cautious investors may consider this stock for its long-term potential.

Fundamental Rating

Baxter's current fundamental rating indicates room for improvement with particular challenges in return and equity metrics.

Category Score Visualization
Overall Score 2
Discounted Cash Flow 4
Return on Equity 1
Return on Assets 1
Debt to Equity 1
Price to Earnings 1
Price to Book 2

Historical Rating

The historical rating shows consistency in Baxter's financial performance over recent periods.

Date Overall DCF ROE ROA D/E P/E P/B
2025-06-09 2 4 1 1 1 1 2
2025-06-09 2 4 1 1 1 1 2

Analyst Price Targets

Analysts remain neutral with price targets emphasizing a hold, ensuring stabilized expectations.

High Low Median Consensus
42 42 42 42
Baxter International Inc. Stock Chart

Analyst Sentiment

Analysts exhibit a cautious outlook with a majority recommending to hold.

Recommendation Count Distribution
Strong Buy 0
Buy 16
Hold 18
Sell 1
Strong Sell 0

Conclusion

Baxter International Inc. presents a mixed investment opportunity with stable aspects in cash flow contrasted by lower performance in equity-based metrics. While the analyst consensus indicates a hold, the company's innovative healthcare solutions and global presence offer long-term growth potential. Investors should weigh these factors before making investment decisions. The company’s historical rating consistency may appeal to those preferring risk-adjusted strategies. Ultimately, it is a stock with both risks and room for growth contingent on effective management and market conditions.